Carbapenem resistance and hypervirulence in <i>Klebsiella pneumoniae</i> are raising global public health concerns in the 21<sup>st</sup> century. [PDF]
Thacharodi A +5 more
europepmc +1 more source
Unraveling Cefiderocol Resistance in NDM- and OXA-48-like Co-Producing <i>Klebsiella pneumoniae</i> Isolates Through Integrated Genomic and Phenotypic Analysis. [PDF]
Ambretti S +5 more
europepmc +1 more source
Antimicrobial activity of ceftolozane/tazobactam, imipenem/relebactam, and comparators against Gram-negative pathogens collected in Arabian Gulf countries: SMART 2020-2024. [PDF]
Wise MG +5 more
europepmc +1 more source
Resistance to novel β-lactam/β-lactamase inhibitors among carbapenem-resistant <i>Pseudomonas aeruginosa</i> and clinical implications in the prospective observational <i>Pseudomonas</i> study. [PDF]
Gottesdiener LS +31 more
europepmc +1 more source
Clinical Characteristics, Antimicrobial Resistance Profiles and Carbapenemases Genotypes of <i>Providencia rettgeri</i>: A 5-Year Retrospective Study in a Tertiary Teaching Hospital in Northern China. [PDF]
Li Y +8 more
europepmc +1 more source
Difficult-to-treat resistance (DTR), treatment, and outcomes of carbapenem-resistant Enterobacterales infections in the setting of IMP-type carbapenemase predominance in Japan. [PDF]
Ohyama K +21 more
europepmc +1 more source

